We are monitoring the impact of COVID-19 on Vaccine Adjuvant Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 623
Share on
Share on

Global Vaccine Adjuvant Market Size, Share, Trends and Growth Analysis Report – Segmented By Type, Route of Administration, Mechanism of Action and Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 623
Pages: 175

Vaccine Adjuvant Market Size (2020 to 2025)

As per our research report, the size of the global vaccine adjuvant market is forecasted to grow USD 967.66 million by 2025, which was worth USD 579.46 million in 2020. The market is estimated to showcase a CAGR of 10.8% during the forecast period.

The global vaccine adjuvants market comprises of veterinary and human adjuvants which are used to increase the efficiency of vaccines. Vaccine adjuvants are accredited with assisting to boost the immune response in the host post-vaccination. Immunologists and infectious disease specialists are in covenant over the advantageous uses of adjuvants in vaccines today. Notably, as a means to decrease the number of doses, surge the probability of a continuous immunological response and reduce the overall prevalence of the disease.

The immune response to vaccine antigens has been improved with the use of adjuvants for decades. They recover the body's immune reaction and frequently allow for lesser amounts of a deactivated virus or bacteria to be used in a vaccine. However, more than one adjuvant may be present in the final vaccine product.

MARKET DRIVERS 

Increasing incidence of infectious and zoonotic diseases, growing focus on vaccination programs by numerous government bodies, and rising focus on enhanced and long-term immunization besides current and emerging diseases are primarily accelerating the global vaccine adjuvant market. Additionally, growing R&D expenditure, as well as attainments, associations, and agreements by companies, is another major factor driving the growth of this market. Advancements in adjuvant formulations, the growing adoption rate of recombinant subunit, and synthetic vaccines are providing an additional boost to the global vaccine adjuvant market.

Growth opportunities that are likely to boost the global vaccine adjuvant market are growing demand for vaccine adjuvants, untouched market areas in developing countries are offering sizable shares for adjuvant vaccine manufacturers and key players in the market.

MARKET RESTRAINTS

But Side effects associated with the adjuvants and high toxicity adjuvants is the primary restraint to the global vaccine adjuvant market.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Type, Route of administration, Mechanism of action and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This market research report on the global vaccine adjuvant market has been segmented based on the type, route of administration, mechanism of action, and region.

Vaccine Adjuvant Market – By Type:

  • Aluminum Salts
  • Tensoactive Adjuvants
  • Adjuvant Emulsions
  • Bacteria Derived Adjuvants
  • Liposome Adjuvants
  • Carbohydrate Adjuvants

Based on type, the Carbohydrate adjuvants segment is contributing significant share and is anticipated to increase further during the forecast period.

The aluminum salts type segment is estimated to grow at a healthy CAGR during the forecast period due to rising innovation and introduction of particulate adjuvants in the market. Aluminum salts vaccine has a presence and growing continuously in the market since the last two decades due to the safety of cancer patients. Also, new adjuvants have come up with an innovative facility such as more muscular battle to disease and having a more shelf life as compared to others, due to easier availability of aluminum salts in the nature and high adoption of particulate vaccines.

Vaccine Adjuvant Market – By Route of administration:

  • Oral
  • Intradermal
  • Subcutaneous
  • Intranasal
  • Intramuscular

Based on the route of administration, the Intramuscular segment is dominating the vaccine adjuvants market regarding the route of administration as this is the fastest and highly effective route. The intradermal route segment is likely to contribute a significant share to the market as it takes more time for absorption and action. 

Vaccine Adjuvant Market – By Mechanism of Action:

  • Immune Stimulants
  • Carriers
  • Vehicle Adjuvants

Based on the mechanism of action, the Immune Stimulants segment is dominating the market owing to the high demand of adjuvants for stimulating antigens to the immune system.

Vaccine Adjuvant Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

North America, followed by Europe, lead the vaccine adjuvants market. Growth in the North American segment is mainly driven by the fast increasing elderly population and rising government funding in North American countries. Also, the North American market is overgrowing owing to innovations and increasing product portfolios of the key players, a rise in investments of R & D.

The European market is dominating due to an increase in the population of patients affected by diseases like cancer and other infections. The Asia Pacific and Africa are displaying consistent growth and expected to maintain the trend due to the increasing population and occurrence of diseases like HIV, hepatitis, cancer, influenza, and others.

TOP COMPANIES IN THE MARKET

The key players in the vaccine adjuvants market include MPV Technologies (U.S.), Avanti Polar Lipids, Novavax Inc. (U.S.), Brenntag Biosector (Denmark), SEPPIC (France), Agenus, Inc. (U.S.), Invivogen (U.S.), SPI Pharma, Inc. (U.S.), CSL Limited (Australia), and OZ Biosciences (France).

RECENT MARKET DEVELOPMENTS

In 2020, The U.S. food and drug administration has approved to Seqirus for its new product AUNDEZ for the treatment of Influenza prevention. It is the first monovalent vaccine adjuvant to protect against influenza A H5N1 in the pandemic situation.

In 2020, GSK has announced it comes into the market with innovative doses of vaccine adjuvant to enhance the development of the COVID-19 outbreak. GSK has invested a high amount in developing 1 billion doses of adjuvanted vaccine next year.

In 2018, Croda acquired the Brenntag bio sector to develop an adjuvant vaccine for serving humans as well as the veterinary market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 South Korea           

                                6.3.6 Australia   

                6.4 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Mexico     

                                6.4.4 Argentina

                                6.4.5 Rest of Latin America          

                6.5 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1.  
  2.  
  3. Global Vaccine Adjuvant Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  5. Global Aluminium Salts Market, By Region, From 2020 to 2025 (USD Million)
  6. Global Tensoactive Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  7. Global Adjuvant Emulsions Market, By Region, From 2020 to 2025 (USD Million)
  8. Global Bacteria derived Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  9. Global Liposome Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  10. Global Carbohydrate Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  11. Global Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  12. Global Oral Market, By Region, From 2020 to 2025 (USD Million)
  13. Global Intradermal Market, By Region, From 2020 to 2025 (USD Million)
  14. Global Subcutaneous Market, By Region, From 2020 to 2025 (USD Million)
  15. Global Intranasal Market, By Region, From 2020 to 2025 (USD Million)
  16. Global Intramuscular Market, By Region, From 2020 to 2025 (USD Million)
  17. Global Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  18. Global Immuno Stimulants Market, By Region, From 2020 to 2025 (USD Million)
  19. Global Carriers Market, By Region, From 2020 to 2025 (USD Million)
  20. Global Vehicle Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  21. North America Vaccine Adjuvant Market, By Region, From 2020 to 2025 (USD Million)
  22. North America Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  23. North America Aluminium Salts Market, By Region, From 2020 to 2025 (USD Million)
  24. North America Tensoactive Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  25. North America Adjuvant Emulsions Market, By Region, From 2020 to 2025 (USD Million)
  26. North America Bacteria derived Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  27. North America Liposome Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  28. North America Carbohydrate Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  29. North America Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  30. North America Oral Market, By Region, From 2020 to 2025 (USD Million)
  31. North America Intradermal Market, By Region, From 2020 to 2025 (USD Million)
  32. North America Subcutaneous Market, By Region, From 2020 to 2025 (USD Million)
  33. North America Intranasal Market, By Region, From 2020 to 2025 (USD Million)
  34. North America Intramuscular Market, By Region, From 2020 to 2025 (USD Million)
  35. North America Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  36. North America Immuno Stimulants Market, By Region, From 2020 to 2025 (USD Million)
  37. North America Carriers Market, By Region, From 2020 to 2025 (USD Million)
  38. North America Vehicle Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  39. United States Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  40. United States Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  41. United States Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  42. Canada Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  43. Canada Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  44. Canada Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  45. Europe Vaccine Adjuvant Market, By Region, From 2020 to 2025 (USD Million)
  46. Europe Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  47. Europe Aluminium Salts Market, By Region, From 2020 to 2025 (USD Million)
  48. Europe Tensoactive Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  49. Europe Adjuvant Emulsions Market, By Region, From 2020 to 2025 (USD Million)
  50. Europe Bacteria derived Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  51. Europe Liposome Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  52. Europe Carbohydrate Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  53. Europe Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  54. Europe Oral Market, By Region, From 2020 to 2025 (USD Million)
  55. Europe Intradermal Market, By Region, From 2020 to 2025 (USD Million)
  56. Europe Subcutaneous Market, By Region, From 2020 to 2025 (USD Million)
  57. Europe Intranasal Market, By Region, From 2020 to 2025 (USD Million)
  58. Europe Intramuscular Market, By Region, From 2020 to 2025 (USD Million)
  59. Europe Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  60. Europe Immuno Stimulants Market, By Region, From 2020 to 2025 (USD Million)
  61. Europe Carriers Market, By Region, From 2020 to 2025 (USD Million)
  62. Europe Vehicle Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  63. U.K Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  64. U.K Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  65. U.K Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  66. Spain Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  67. Spain Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  68. Spain Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  69. Germany Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  70. Germany Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  71. Germany Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  72. Italy Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  73. Italy Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  74. Italy Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  75. France Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  76. France Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  77. France Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  78. Asia-Pacific Vaccine Adjuvant Market, By Region, From 2020 to 2025 (USD Million)
  79. Asia-Pacific Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  80. Asia-Pacific Aluminium Salts Market, By Region, From 2020 to 2025 (USD Million)
  81. Asia-Pacific Tensoactive Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  82. Asia-Pacific Adjuvant Emulsions Market, By Region, From 2020 to 2025 (USD Million)
  83. Asia-Pacific Bacteria derived Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  84. Asia-Pacific Liposome Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  85. Asia-Pacific Carbohydrate Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  86. Asia-Pacific Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  87. Asia-Pacific Oral Market, By Region, From 2020 to 2025 (USD Million)
  88. Asia-Pacific Intradermal Market, By Region, From 2020 to 2025 (USD Million)
  89. Asia-Pacific Subcutaneous Market, By Region, From 2020 to 2025 (USD Million)
  90. Asia-Pacific Intranasal Market, By Region, From 2020 to 2025 (USD Million)
  91. Asia-Pacific Intramuscular Market, By Region, From 2020 to 2025 (USD Million)
  92. Asia-Pacific Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  93. Asia-Pacific Immuno Stimulants Market, By Region, From 2020 to 2025 (USD Million)
  94. Asia-Pacific Carriers Market, By Region, From 2020 to 2025 (USD Million)
  95. Asia-Pacific Vehicle Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  96. China Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  97. China Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  98. China Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  99. India Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  100. India Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  101. India Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  102. Japan Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  103. Japan Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  104. Japan Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  105. South Korea Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  106. South Korea Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  107. South Korea Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  108. Australia Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  109. Australia Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  110. Australia Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  111. Latin America Vaccine Adjuvant Market, By Region, From 2020 to 2025 (USD Million)
  112. Latin America Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  113. Latin America Aluminium Salts Market, By Region, From 2020 to 2025 (USD Million)
  114. Latin America Tensoactive Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  115. Latin America Adjuvant Emulsions Market, By Region, From 2020 to 2025 (USD Million)
  116. Latin America Bacteria derived Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  117. Latin America Liposome Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  118. Latin America Carbohydrate Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  119. Latin America Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  120. Latin America Oral Market, By Region, From 2020 to 2025 (USD Million)
  121. Latin America Intradermal Market, By Region, From 2020 to 2025 (USD Million)
  122. Latin America Subcutaneous Market, By Region, From 2020 to 2025 (USD Million)
  123. Latin America Intranasal Market, By Region, From 2020 to 2025 (USD Million)
  124. Latin America Intramuscular Market, By Region, From 2020 to 2025 (USD Million)
  125. Latin America Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  126. Latin America Immuno Stimulants Market, By Region, From 2020 to 2025 (USD Million)
  127. Latin America Carriers Market, By Region, From 2020 to 2025 (USD Million)
  128. Latin America Vehicle Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  129. Brazil Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  130. Brazil Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  131. Brazil Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  132. Argentina Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  133. Argentina Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  134. Argentina Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  135. Mexico Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  136. Mexico Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  137. Mexico Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  138. Middle East & Africa Vaccine Adjuvant Market, By Region, From 2020 to 2025 (USD Million)
  139. Middle East & Africa Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  140. Middle East & Africa Aluminium Salts Market, By Region, From 2020 to 2025 (USD Million)
  141. Middle East & Africa Tensoactive Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  142. Middle East & Africa Adjuvant Emulsions Market, By Region, From 2020 to 2025 (USD Million)
  143. Middle East & Africa Bacteria derived Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  144. Middle East & Africa Liposome Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  145. Middle East & Africa Carbohydrate Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  146. Middle East & Africa Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  147. Middle East & Africa Oral Market, By Region, From 2020 to 2025 (USD Million)
  148. Middle East & Africa Intradermal Market, By Region, From 2020 to 2025 (USD Million)
  149. Middle East & Africa Subcutaneous Market, By Region, From 2020 to 2025 (USD Million)
  150. Middle East & Africa Intranasal Market, By Region, From 2020 to 2025 (USD Million)
  151. Middle East & Africa Intramuscular Market, By Region, From 2020 to 2025 (USD Million)
  152. Middle East & Africa Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  153. Middle East & Africa Immuno Stimulants Market, By Region, From 2020 to 2025 (USD Million)
  154. Middle East & Africa Carriers Market, By Region, From 2020 to 2025 (USD Million)
  155. Middle East & Africa Vehicle Adjuvants Market, By Region, From 2020 to 2025 (USD Million)
  156. Middle East Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  157. Middle East Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  158. Middle East Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  159. Africa Vaccine Adjuvant Market, By Type, From 2020 to 2025 (USD Million)
  160. Africa Vaccine Adjuvant Market, By Route of Administration , From 2020 to 2025 (USD Million)
  161. Africa Vaccine Adjuvant Market, By Mechanism of Action, From 2020 to 2025 (USD Million)
  162.  

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample